The safety and efficacy of SGLT2 inhibitors
February 23, 2018
Since the SGLT-2 inhibitors have been launched there have been studies that have suggested potential concerns such as ketoacidosis and amputation and those that have demonstrated positive benefits on cardiovascular outcomes. This meta-analysis of the drugs may dispel the anxieties that some primary care clinicians have had over prescribing them.
http://jaha.ahajournals.org/content/7/2/e007165
Share
